For the Inventor, By the Inventor

Enter assignee name

Ramsey, NJ, United States of America

Alteon Incorporated

USPTO Granted Patents = 55

% Expired Patents = 27.3

Forward Citations = 463

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Dilip R Wagle (31 out of 34 patents)

Peter C Ulrich (26 out of 79 patents)

Anthony Cerami (25 out of 167 patents)

4. John J Egan (9 out of 15 patents)

5. San-Bao Hwang (9 out of 10 patents)

6. Henry W Founds (9 out of 10 patents)

7. Michael E Lankin (8 out of 23 patents)

8. Martin Gall (8 out of 9 patents)

9. Sara Vasan (7 out of 10 patents)

10. David H Shih (5 out of 5 patents)

11. Homayoun Sadeghi (5 out of 5 patents)

12. Edmond Joseph LaVoie (4 out of 63 patents)

13. Stanley Charles Bell (4 out of 55 patents)

14. Richard J Bucala (3 out of 57 patents)

15. Sheng Ding Fang (3 out of 5 patents)

Core Competencies:

Advanced Glycosylation

Monoclonal Antibodies

Thiazole Compounds

Fibrotic Diseases

Glaucoma Treatments

Protein Aging

Heterocyclic Compounds

Glycosylation Inhibition

Pharmaceutical Compositions

Therapeutic Methods

Amino-Benzoic Acids

Hydrazones

55 patents: Sort by Forward Citations

1. 7166625 - Method for treating fibrotic diseases and other indications (2007-01-23),

2. 7144570 - Sunscreen compositions and methods of use thereof (2006-12-05),

3. RE39138 - Monoclonal antibody specific for advanced glycosylation endproducts in biological samples (2006-06-19),

4. 7026342 - Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds (2006-04-11),

5. 7022719 - Preventing and reversing the formation of advance glycosylation endproducts (2006-04-04),

6. 6960605 - Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging (2005-11-01),

7. 6806268 - Method for treating glaucoma V (2004-10-19),

8. 6790859 - Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compounds (2004-09-14),

9. 6770663 - Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds (2004-08-03),

10. 6713498 - Method for treating glaucoma VI (2004-03-30),

11. 6610716 - Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging (2003-08-26),

12. 6596745 - Method for treating fibrotic diseases with azolium chroman compounds (2003-07-22),

13. 6596744 - Method for treating fibrotic diseases or other indications IIC (2003-07-22),

14. 6509480 - Glucose and lipid lowering compounds (2003-01-21),

15. 6506902 - Synthesis of thiazolium compounds (2003-01-14),

Alteon Incorporated, based in Ramsey, NJ, specializes in advanced glycosylation research, focusing on the development of innovative therapies for fibrotic diseases and glaucoma. The company is engaged in the exploration of monoclonal antibodies and thiazole compounds, aiming to address critical health challenges associated with protein aging and glycosylation inhibition. Through its cutting-edge research, Alteon seeks to enhance treatment options and improve patient outcomes in various therapeutic areas.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

55 Patents

#3 in Ramsey, NJ

#266 in New Jersey

#6,448 in US

#12,903 in the World

Ramsey, NJ, United States of America

Alteon Incorporated

Forward Citations = 463

30 inventors:

Dilip R Wagle (31 out of 34 patents)

Peter C Ulrich (26 out of 79 patents)

Anthony Cerami (25 out of 167 patents)

4. John J Egan (9 out of 15 patents)

5. San-Bao Hwang (9 out of 10 patents)

Please report any incorrect information to [email protected]

Loading…